Skip to main content
Clinical Trials/ITMCTR2000003976
ITMCTR2000003976
Not yet recruiting
Phase 1

Multi center randomized controlled clinical trial of Xiezhuo Tongluo Formula in the treatment of chronic kidney disease stage 3-4

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) It met the diagnostic criteria of CKD3\-4
  • (2\) Aged 18 to 75 years old and can sign the informed consent form independently
  • (3\) Blood pressure 100\-160/60\-100mmHg.

Exclusion Criteria

  • (1\) Prepare for renal replacement therapy;
  • (2\) Immunosuppressive therapy were performed;
  • (3\) Patients with acute infection, serious primary diseases of heart, lung, brain, liver and hematopoietic system, diabetic ketoacidosis, malignant tumor, active tuberculosis and psychotic patients;
  • (4\) eGFR fluctuated more than 30% in three months;
  • (5\) Severe hyperkalemia (blood potassium\>6\.5mmol/L);
  • (6\) Allergy history to some components of the drug used;
  • (7\) Pregnant or during lactation;
  • (8\) Participated in other clinical studies.

Outcomes

Primary Outcomes

Not specified

Similar Trials